These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1312 related articles for article (PubMed ID: 33737135)

  • 1. COVID-19: Is herd immunity the only option for fragile Yemen?
    Noushad M; Al-Saqqaf IS
    Int J Infect Dis; 2021 May; 106():79-82. PubMed ID: 33737135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healthcare workers' knowledge, preparedness, counselling practices, and perceived barriers to confront COVID-19: A cross-sectional study from a war-torn country, Yemen.
    Al-Ashwal FY; Kubas M; Zawiah M; Bitar AN; Mukred Saeed R; Sulaiman SAS; Khan AH; Ghadzi SMS
    PLoS One; 2020; 15(12):e0243962. PubMed ID: 33306750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Healthcare System Capabilities and Preparedness in Yemen to Confront the Novel Coronavirus 2019 (COVID-19) Outbreak: A Perspective of Healthcare Workers.
    Zawiah M; Al-Ashwal FY; Saeed RM; Kubas M; Saeed S; Khan AH; Sulaiman SAS; Abduljabbar R
    Front Public Health; 2020; 8():419. PubMed ID: 32850608
    [No Abstract]   [Full Text] [Related]  

  • 4. The Impact of Armed Conflict on the Epidemiological Situation of COVID-19 in Libya, Syria and Yemen.
    Daw MA
    Front Public Health; 2021; 9():667364. PubMed ID: 34178925
    [No Abstract]   [Full Text] [Related]  

  • 5. The dilemma of herd immunity for COVID-19.
    Nejadghaderi SA; Safiri S
    J Med Virol; 2021 May; 93(5):2578-2579. PubMed ID: 33386744
    [No Abstract]   [Full Text] [Related]  

  • 6. Conflict and COVID-19 in Yemen: beyond the humanitarian crisis.
    Alsabri M; Alhadheri A; Alsakkaf LM; Cole J
    Global Health; 2021 Jul; 17(1):83. PubMed ID: 34294097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herd immunization with childhood vaccination may provide protection against COVID-19.
    Yu Y
    Acta Microbiol Immunol Hung; 2020 Sep; 67(3):198-200. PubMed ID: 32986604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digital herd immunity and COVID-19.
    Bulchandani VB; Shivam S; Moudgalya S; Sondhi SL
    Phys Biol; 2021 Jun; 18(4):. PubMed ID: 33827059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Could COVID-19 be contained in poor populations by herd immunity rather than by strategies designed for affluent societies or potential vaccine(s)?
    Ruppel A; Halim MI; Kikon R; Mohamed NS; Saebipour MR
    Glob Health Action; 2021 Jan; 14(1):1863129. PubMed ID: 33397199
    [No Abstract]   [Full Text] [Related]  

  • 10. Overcoming COVID-19 in West African countries: is herd immunity an option?
    Ilesanmi OS; Akande A; Afolabi AA
    Pan Afr Med J; 2020; 35(Suppl 2):103. PubMed ID: 33282058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 case fatality rates can be highly misleading in resource-poor and fragile nations: the case of Yemen.
    Noushad M; Al-Saqqaf IS
    Clin Microbiol Infect; 2021 Apr; 27(4):509-510. PubMed ID: 33429029
    [No Abstract]   [Full Text] [Related]  

  • 12. Herd Immunity Against COVID-19: More Questions Than Answers.
    Russell RS
    Viral Immunol; 2021 May; 34(4):211-212. PubMed ID: 33999721
    [No Abstract]   [Full Text] [Related]  

  • 13. Excess mortality during the COVID-19 pandemic: a geospatial and statistical analysis in Aden governorate, Yemen.
    Koum Besson ES; Norris A; Bin Ghouth AS; Freemantle T; Alhaffar M; Vazquez Y; Reeve C; Curran PJ; Checchi F
    BMJ Glob Health; 2021 Mar; 6(3):. PubMed ID: 33758012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
    Frederiksen LSF; Zhang Y; Foged C; Thakur A
    Front Immunol; 2020; 11():1817. PubMed ID: 32793245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Field Epidemiology Training Program Response to COVID-19 During a Conflict: Experience From Yemen.
    Al Serouri AA; Ghaleb YA; Al Aghbari LA; Al Amad MA; Alkohlani AS; Almoayed KA; Jumaan AO
    Front Public Health; 2021; 9():688119. PubMed ID: 34881214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Long Way to the Recovery: COVID-19 Will Not Disappear.
    Jung J
    J Korean Med Sci; 2021 Aug; 36(32):e231. PubMed ID: 34402229
    [No Abstract]   [Full Text] [Related]  

  • 17. How to Understand Herd Immunity in the Context of COVID-19.
    Dong M; He F; Deng Y
    Viral Immunol; 2021 Apr; 34(3):174-181. PubMed ID: 33351708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Herd Immunity to COVID-19 in Louisiana Nursing Homes.
    Reilly TA
    J Am Med Dir Assoc; 2021 Feb; 22(2):256-257. PubMed ID: 33358724
    [No Abstract]   [Full Text] [Related]  

  • 19. COVID-19 and immunity: quo vadis?
    Miyasaka M
    Int Immunol; 2021 Sep; 33(10):507-513. PubMed ID: 33569606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individuals cannot rely on COVID-19 herd immunity: Durable immunity to viral disease is limited to viruses with obligate viremic spread.
    Yewdell JW
    PLoS Pathog; 2021 Apr; 17(4):e1009509. PubMed ID: 33901246
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 66.